Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 3/20 | 0.47 |
| ▸ | PPM1B | O75688 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | PRKCA | P17252 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9463642 | 0.89 | MIF (0.49) | MIFALDH1A1SMN1; SMN2PRKCATDP1 | |
| SCHEMBL3070093 | 0.89 | MIF (0.49) | MIFALDH1A1SMN1; SMN2PRKCATDP1 | |
| SCHEMBL3069917 | 0.85 | NAAA (0.56) | MIFALDH1A1PRKCATDP1 | |
| SCHEMBL3062283 | 0.83 | — | — | |
| SCHEMBL7804568 | 0.83 | — | — | |
| SCHEMBL7803427 | 0.83 | — | — | |
| SCHEMBL28263792 | 0.82 | MGAM (0.44) | MIFALDH1A1 | |
| SCHEMBL19287024 | 0.81 | DGKA (0.41) | MIFPPM1BPTPN1PPP1CCALDH1A1 | |
| SCHEMBL14477600 | 0.81 | ALDH1A1 (0.41) | ALDH1A1TDP1 | |
| SCHEMBL15878938 | 0.80 | ALDH1A1 (0.39) | MIFALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3124618-B1 | METHOD FOR SEPARATING AND CONCENTRATING TARGET SUBSTANCE USING NOVEL CATIONIC GRAFT POLYMER | NITTO BOSEKI CO LTD (JP) | 2019-05-15 | — | — | EP | disclosed |
| US-5032590-A | Substituted hydroxylamines | BAYER AKTIENGESELLSCHAFT (DE) | 1991-07-16 | — | — | US | disclosed |
| US-4968681-A | Substituted hydroxylamines | BAYER AKTIENGESELLSCHAFT (DE) | 1990-11-06 | — | — | US | disclosed |
| WO-1990011075-A1 | ANGIOGENIC MONOBUTYRIN AND ITS ANALOGS | DANA FARBER CANCER INSTITUTE (US) | 1990-10-04 | — | — | WO | disclosed |
| CN-1033991-A | SUBSTITUTED HYDROXYLAMINES | BAYER AG (DE) | 1989-07-19 | — | — | CN | disclosed |